Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Should Income Investors Buy This Blue Chip Dividend Stock?
10:00am, Friday, 05'th May 2023
Bristol Myers Squibb grew its profits in the first quarter. The company's generous dividend appears to be sustainable.
Best Dividend Stocks To Buy In 2023? 2 To Know
06:54am, Thursday, 04'th May 2023
Dividend stocks to watch in the stock market today.
Want Passive Income at a Fair Price? Consider Buying This Dividend Growth Stock
08:20am, Wednesday, 03'rd May 2023
Bristol-Myers Squibb isn't a star-studded growth stock, but its valuation is fair. The next couple of years might be a bit slow for shareholders.
Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding
01:12pm, Tuesday, 02'nd May 2023
Can-Fite BioPharma Ltd. NYSEAMERICAN: CANF is an Israel-based biotechnology firm that develops small-molecule therapeutic treatments for cancers, inflammatory diseases and sexual dysfunction.
Bristol-Myers (BMY) Q1 Earnings Beat, Revlimid Generics Hurt Sales
01:42pm, Thursday, 27'th Apr 2023
Bristol-Myers' (BMY) first-quarter 2023 earnings top estimates, while sales missed the same and declined year over year due to generic erosion for the oncology drug Revlimid.
Bristol Myers Squibb (BMY) Surpasses Q1 Earnings Estimates
09:53am, Thursday, 27'th Apr 2023
Bristol Myers Squibb (BMY) came out with quarterly earnings of $2.05 per share, beating the Zacks Consensus Estimate of $1.98 per share. This compares to earnings of $1.96 per share a year ago.
Bristol Myers Q1 profit beats while revenue falls slightly short of estimates
07:21am, Thursday, 27'th Apr 2023
Bristol Myers Squibb Co. BMY posted net income of $2.262 billion, or $1.07 a share, for the first quarter, up from $1.278 billion, or 59 cents a share, in the year-earlier period. Adjusted per-share e
Markets Continue Steady Slide; META, EBAY Beat Q1 Earnings
07:46pm, Wednesday, 26'th Apr 2023
Except the Nasdaq, which snapped a two-day losing streak and was the only major index in the green all day.
Drug/Biotech Stocks' Q1 Earnings Due Apr 27: LLY, ABBV & More
10:40am, Wednesday, 26'th Apr 2023
Let's look at the five biotech/pharma companies slated to release quarterly results on Apr 27.
Will Bristol Myers Squibb Stock Rise Post Q1?
06:30am, Wednesday, 26'th Apr 2023
We expect BMY stock to trade higher, with its revenue and earnings coming in marginally above the street estimates.
Q1 Earnings Scorecard and Fresh Analyst Reports for Bristol-Myers, Medtronic & Altria Group
03:12pm, Tuesday, 25'th Apr 2023
Q1 Earnings Season Scorecard is included in today's Research Daily in addition to new research reports on Bristol-Myers (BMY), Medtronic(MDT) and Altria Group (MO).
Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock
11:33am, Tuesday, 25'th Apr 2023
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Bristol-Myers (BMY) to Report Q1 Earnings: What+'s in Store?
01:41pm, Monday, 24'th Apr 2023
Investors are likely to focus on the demand for Eliquis and Opdivo along with an incremental contribution from newer drugs when Bristol-Myers (BMY) reports Q1 results.
Bristol-Myers Squibb: A Recession-Resistant Route Forward
05:00pm, Tuesday, 18'th Apr 2023
Bristol-Myers Squibb: A Recession-Resistant Route Forward
Bristol Myers (BMY), TSVT Application for Abecma Accepted
02:26pm, Monday, 17'th Apr 2023
Bristol Myers (BMY) and partner TSVTs sBLA for CAR T cell therapy is accepted by the FDA for earlier lines of treatment in multiple myeloma.
